Pierre Bet Selected Research

Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)

1/2024	Improving Methylphenidate Titration in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): A Randomized Controlled Trial Using Placebo-Controlled Titration Implemented in Clinical Practice.
3/2023	Methylphenidate dose-response in children with ADHD: evidence from a double-blind, randomized placebo-controlled titration trial.
1/2022	Meta-analysis: Dose-Dependent Effects of Methylphenidate on Neurocognitive Functioning in Children With Attention-Deficit/Hyperactivity Disorder.
11/2020	Methylphenidate-Related Improvements in Math Performance Cannot Be Explained by Better Cognitive Functioning or Higher Academic Motivation: Evidence From a Randomized Controlled Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pierre Bet Research Topics

Disease

4	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2024 - 11/2020
1	Obesity 01/2022
1	Attention Deficit and Disruptive Behavior Disorders (Disruptive Behavior Disorder) 12/2018
1	Antisocial Personality Disorder (Antisocial Personality) 12/2018
1	Body Weight (Weight, Body) 10/2009

Drug/Important Bio-Agent (IBA)

5	Methylphenidate (Ritalin)FDA LinkGeneric 01/2024 - 12/2018
1	SolutionsIBA 01/2022
1	Dopamine Agonists (Dopamine Agonist)IBA 12/2018
1	SodiumIBA 10/2009
1	dodecaborateIBA 10/2009
1	4-boronophenylalanineIBA 10/2009